Amgen (NASDAQ: AMGN) announced the submission of a Biologics License Application (BLA) with the United States (U.S.) Food and Drug ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE